<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               6	ADVERSE REACTIONS<BR>               <BR>                  The following adverse reactions are described in detail in other labeling sections: <BR>                  <BR>                     Neutropenia and thrombocytopenia [see Boxed Warnings, Warnings and Precautions (5.3)]<BR>                     <BR>                     Deep vein thrombosis and pulmonary embolism [see Boxed Warnings, Warnings and Precautions (5.4)]<BR>                     <BR>                     Allergic Reactions   [see Warnings and Precautions (5.5)]<BR>                     <BR>                     Tumor lysis syndrome [see Warnings and Precautions (5.6)]<BR>                     <BR>                     Tumor flare reactions [see Warnings and Precautions (5.7)]<BR>                     <BR>                     Hepatotoxicity [see Warnings and Precautions (5.8)]<BR>                     <BR>                     Second Primary Malignancies [see Warnings and Precautions (5.9)]<BR>                     <BR>                  <BR>                  Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           MM:  Most common adverse reactions (â‰¥20%) include fatigue, neutropenia, constipation, diarrhea, muscle cramp, anemia, pyrexia, peripheral edema, nausea, back pain, upper respiratory tract infection, dyspnea, dizziness, thrombocytopenia, tremor and rash (6.1)<BR>                           MDS: Most common adverse reactions (>15%) include thrombocytopenia, neutropenia, diarrhea, pruritus, rash, fatigue, constipation, nausea, nasopharyngitis, arthralgia, pyrexia, back pain, peripheral edema, cough, dizziness, headache, muscle cramp, dyspnea, pharyngitis, and epistaxis (6.2)<BR>                        <BR>                        <BR>                           To report SUSPECTED ADVERSE REACTIONS or embryo-fetal exposure: contact Celgene Corporation at 1-888-423-5436 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.1		Clinical Trials Experience in Multiple Myeloma<BR>                     <BR>                        Data were evaluated from 703 patients in two studies who received at least one dose of REVLIMID/dexamethasone (353 patients) or placebo/dexamethasone (350 patients).<BR>                        In the REVLIMID/dexamethasone treatment group, 269 patients (76%) underwent at least one dose interruption with or without a dose reduction of REVLIMID compared to 199 patients (57%) in the placebo/dexamethasone treatment group. Of these patients who had one dose interruption with or without a dose reduction, 50% in the REVLIMID/dexamethasone treatment group underwent at least one additional dose interruption with or without a dose reduction compared to 21% in the placebo/dexamethasone treatment group. Most adverse events and Grade 3/4 adverse events were more frequent in patients who received the combination of REVLIMID/dexamethasone compared to placebo/dexamethasone. <BR>                        Tables 3, 4, and 5 summarize the adverse reactions reported for REVLIMID/dexamethasone and placebo/dexamethasone groups.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="800"><BR>                           <caption>Table 3:	Adverse Reactions Reported in &#8805;5% of Patients and with a &#8805;2% Difference in Proportion of Patients Between the REVLIMID/dexamethasone and Placebo/dexamethasone Groups</caption><BR>                           <tbody><BR>                              <tr styleCode="Botrule"><BR>                                 <td align="left" valign="top" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">System Organ Class/ Preferred Term</content><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">REVLIMID/Dex*  <br/>(n=353)<br/>n (%)</content><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Placebo/Dex *<br/>(n=350)<br/>n (%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Blood and lymphatic system disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Neutropenia <sup>%</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">149 (42.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">22 (6.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Anemia <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">111 (31.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">83 (23.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Thrombocytopenia <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">76 (21.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">37 (10.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Leukopenia </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">28 (7.9)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">4 (1.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Lymphopenia</td><BR>                                 <td align="center" styleCode="Lrule Rrule">19 (5.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">5 (1.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold"> General disorders and administration site conditions</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Fatigue</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">155  (43.9) </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">146 (41.7) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Pyrexia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">97  (27.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">82 (23.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Peripheral edema</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">93 (26.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">74 (21.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Chest Pain</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">29 ( 8.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">20 (5.7)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Lethargy</td><BR>                                 <td align="center" styleCode="Lrule Rrule">24 ( 6.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">8 (2.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Gastrointestinal disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Constipation</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">143 (40.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">74 (21.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Diarrhea<sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">136 (38.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">96 (27.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Nausea <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">92 (26.1)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">75 (21.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Vomiting <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">43 (12.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">33 (9.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Abdominal Pain <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">35 (9.9)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">22 (6.3)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Dry Mouth</td><BR>                                 <td align="center" styleCode="Lrule Rrule">25 (7.1)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">13 (3.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Musculoskeletal and connective tissue disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Muscle cramp</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">118 (33.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">74 (21.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Back pain</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">91 (25.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">65 (18.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Bone Pain</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">48 (13.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">39 (11.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Pain in Limb</td><BR>                                 <td align="center" styleCode="Lrule Rrule">42 (11.9)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">32 (9.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Nervous system disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Dizziness</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">82 (23.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">59 (16.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Tremor</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">75 (21.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">26 (7.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Dysgeusia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">54 (15.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">34 (9.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Hypoaesthesia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">36 (10.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">25 (7.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Neuropathy <sup>a</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">23 (6.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">13 (3.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Respiratory, Thoracic and Mediastinal Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Dyspnea</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">83 (23.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">60 (17.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Nasopharyngitis</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">62 (17.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">31 (8.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Pharyngitis</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">48 (13.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">33 (9.4)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Bronchitis </td><BR>                                 <td align="center" styleCode="Lrule Rrule">40 (11.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">30 (8.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Infections<sup>b</sup> and infestations</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Upper respiratory tract infection </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">87 (24.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">55 (15.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Pneumonia <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">48 (13.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">29 (8.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Urinary Tract Infection</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">30 (8.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">19 (5.4)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Sinusitis </td><BR>                                 <td align="center" styleCode="Lrule Rrule">26 (7.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">16 (4.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Skin and subcutaneous system disorders </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Rash <sup>c</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">75 (21.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">33 (9.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Sweating Increased</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">35 (9.9)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">25 (7.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Dry Skin</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">33 (9.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">14 (4.0)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Pruritus</td><BR>                                 <td align="center" styleCode="Lrule Rrule">27 (7.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">18 (5.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Metabolism and nutrition disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Anorexia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">55 (15.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">34 (9.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Hypokalemia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">48 (13.6)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">21 (6.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Hypocalcemia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">31 (8.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">10 (2.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Appetite Decreased </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">24 (6.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">14 (4.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Dehydration</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">23 (6.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">15 (4.3)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Hypomagnesaemia</td><BR>                                 <td align="center" styleCode="Lrule Rrule">24 (6.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">10 (2.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Investigations</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Weight Decreased</td><BR>                                 <td align="center" styleCode="Lrule Rrule">69 (19.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">52 (14.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Eye disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Blurred vision</td><BR>                                 <td align="center" styleCode="Lrule Rrule">61 (17.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">40 (11.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Vascular disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Deep vein thrombosis <sup>%</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">33 (9.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">15 (4.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Hypertension </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">28 (7.9)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">20 (5.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Hypotension </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">25 (7.1)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">15 (4.3)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR><BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="800" ID="table4"><BR>                           <caption> Table 4: Grade 3/4 Adverse Reactions Reported in &#8805;2% Patients and With a &#8805;1% Difference in Proportion of Patients Between the REVLIMID/dexamethasone and Placebo/dexamethasone groups</caption><BR>                           <tbody><BR>                              <tr styleCode="Botrule"><BR>                                 <td align="left" valign="top" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">System Organ Class/ Preferred Term</content><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">REVLIMID/Dex<sup>#</sup><BR>                                       <br/>(n=353)<br/>n (%)</content><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Placebo/Dex<sup>#</sup><BR>                                       <br/>(n=350)<br/>n (%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Blood and lymphatic system disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Neutropenia <sup>%</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">118 (33.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">12 (3.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Thrombocytopenia <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">43 (12.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">22 (6.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Anemia <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">35 (9.9)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">20 (5.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Leukopenia </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">14 (4.0)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">1 (0.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Lymphopenia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">10 (2.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">4 (1.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Febrile Neutropenia <sup>%</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">8 (2.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">0 (0.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">General disorders and administration site conditions</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Fatigue</td><BR>                                 <td align="center" styleCode="Lrule Rrule">23 (6.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">17 (4.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Vascular disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Deep vein thrombosis <sup>%</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">29 (8.2)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">12 (3.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Infections<sup>b</sup> and infestations</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Pneumonia <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">30 (8.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">19 (5.4)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Urinary Tract Infection </td><BR>                                 <td align="center" styleCode="Lrule Rrule">5 (1.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">1 (0.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Metabolism and nutrition disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Hypokalemia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">17 (4.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">5 (1.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Hypocalcemia</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">13 (3.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">6 (1.7)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Hypophosphatemia</td><BR>                                 <td align="center" styleCode="Lrule Rrule">9 (2.5)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">0 (0.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Respiratory, thoracic and mediastinal disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Pulmonary embolism<sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">14 (4.0)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">3 (0.9)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Respiratory Distress <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">4 (1.1)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">0 (0.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Musculoskeletal and connective tissue disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Muscle weakness </td><BR>                                 <td align="center" styleCode="Lrule Rrule">20 (5.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">10 (2.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Gastrointestinal disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Diarrhea <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">11 (3.1)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">4 (1.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Constipation</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">7 (2.0)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">1 (0.3)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Nausea <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">6 (1.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">2 (0.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Cardiac disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Atrial fibrillation <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">13 (3.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">4 (1.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Tachycardia </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">6 (1.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">1 (0.3)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Cardiac Failure Congestive <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">5 (1.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">1 (0.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Nervous System disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Syncope</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">10 (2.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">3 (0.9)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Dizziness</td><BR>                                 <td align="center" styleCode="Lrule Rrule">7 (2.0)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">3  (0.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Eye Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Cataract	</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">6 (1.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">1 (0.3)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Cataract Unilateral</td><BR>                                 <td align="center" styleCode="Lrule Rrule">5 (1.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">0 (0.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Psychiatric Disorder</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Depression</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">10 (2.8)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">6 (1.7)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR><BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="800" ID="table5"><BR>                           <caption> Table 5: Serious Adverse Reactions Reported in &#8805;1% Patients and With a &#8805;1% Difference in Proportion of Patients Between the REVLIMID/dexamethasone and Placebo/dexamethasone Groups  </caption><BR>                           <tfoot><BR>                              <tr><BR>                                 <td colspan="3">For all tables above:<br/><BR>                                                n &#8211; Number of Patients<br/><BR>                                                * - All Treatment Emergent AEs with &#8805;5% of Patients in REVLIMID/ Dex and at Least 2% Difference in Proportion between the Two Arms - (Safety population)<br/><BR>                                                # - All Treatment Emergent Grades 3 and 4 AEs with &#8805;1% Patients in REVLIMID/ Dex and at Least 1% Difference in Proportion between the Two Arms - (Safety population)<br/><BR>                                                &amp; - All Treatment Emergent Serious AEs with &#8805;1% Patients in REVLIMID/ Dex and at Least 1% Difference in Proportion between the Two Arms - (Safety population)<br/><BR>                                                @ - ADRs with Death as an outcome<br/><BR>                                                % - ADRs which were considered to be life threatening (if the outcome of the event was death, it is included with death cases)<br/><BR>                                    <sup>a</sup> - All PTs under the MedDRA SMQ of Neuropathy of a peripheral sensory nature will be considered listed<br/><BR>                                    <sup>b</sup> - All PTs under SOC of Infections except for rare infections of Public Health interest will be considered listed<br/><BR>                                    <sup>c</sup>-  All  PTs under HLT of Rash will be considered listed<br/><BR>                                                Dex=dexamethasone<br/><BR>                                                Median duration of exposure among patients treated with REVLIMID/dexamethasone was 44 weeks while median duration of exposure among patients treated with placebo/dexamethasone was 23 weeks. This should be taken into consideration when comparing frequency of adverse events between two treatment groups REVLIMID/dexamethasone vs. placebo/dexamethasone.</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr styleCode="Botrule"><BR>                                 <td align="left" valign="top" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">System Organ Class/ Preferred Term</content><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">REVLIMID/Dex<sup>&amp;</sup><BR>                                       <br/>(n=353)<br/>n (%)</content><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Placebo/Dex<sup>&amp;</sup><BR>                                       <br/>(n=350)<br/>n (%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Blood and lymphatic system disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Febrile Neutropenia<sup>%</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">6 (1.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">0 (0.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Vascular disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Deep vein thrombosis<sup>%</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">26 (7.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">11 (3.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Infections<sup>b</sup> and infestations</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Pneumonia <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">33 (9.3)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">21 (6.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Respiratory, thoracic, and mediastinal disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Pulmonary embolism<sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">13 (3.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">3 (0.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Cardiac disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Atrial fibrillation <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">11 (3.1)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">2 (0.6)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Cardiac Failure Congestive <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">5 (1.4)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">0 (0.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Nervous system disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Cerebrovascular accident <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">7 (2.0)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">3 (0.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Gastrointestinal disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">Diarrhea <sup>@</sup><BR>                                 </td><BR>                                 <td align="center" styleCode="Lrule Rrule">6 (1.7)</td><BR>                                 <td align="center" styleCode="Lrule Rrule">2 (0.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule Botrule"><BR>                                    <content styleCode="bold">Musculoskeletal and connective tissue disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule Botrule">Bone Pain</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">4 (1.1)</td><BR>                                 <td align="center" styleCode="Lrule Rrule Botrule">0 (0.0)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR><BR>                           Venous Thromboembolism <BR>                        <BR>                        <BR>                           Deep Vein Thrombosis and Pulmonary Embolism <BR>                           [see Warnings and Precautions (5.3)]<BR>                        <BR>                        Deep vein thrombosis (DVT) was reported as a serious adverse drug reaction (7.4%) or Grade 3/4 (8.2%) at a higher rate in the REVLIMID/dexamethasone group compared to 3.1 % and 3.4%  in the placebo/dexamethasone group, respectively.  Discontinuations due to DVT adverse reactions were reported at comparable rates between groups.<BR>                        Pulmonary embolism (PE) was reported as a serious adverse drug reaction including Grade 3/4 (3.7%) at a higher rate in the REVLIMID/dexamethasone group compared to 0.9% in the placebo/dexamethasone group.  Discontinuations due to PE adverse reactions were reported at comparable rates between groups.<BR>                        <BR>                           Other Adverse Reactions<BR>                        <BR>                        In these clinical studies of REVLIMID in patients with multiple myeloma, the following adverse drug reactions (ADRs) not described above that occurred at â‰¥1% rate and of at least twice of the placebo percentage rate were reported:<BR>                        <BR>                           Blood and lymphatic system disorders: pancytopenia, autoimmune hemolytic anemia<BR>                        <BR>                           Cardiac disorders: bradycardia, myocardial infarction, angina pectoris<BR>                        <BR>                           Endocrine disorders:  hirsutism<BR>                        <BR>                           Â Eye disorders:    blindness, ocular hypertension<BR>                        <BR>                           Gastrointestinal disorders:  gastrointestinal hemorrhage, glossodynia<BR>                        <BR>                           General disorders and administration site conditions:   malaise<BR>                        <BR>                           Investigations:  liver function tests abnormal, alanine aminotransferase increased<BR>                        <BR>                           Nervous system disorders: cerebral ischemia<BR>                        <BR>                           Psychiatric disorders: mood swings, hallucination, loss of libido<BR>                        <BR>                           Reproductive system and breast disorders: erectile dysfunction<BR>                        <BR>                           Respiratory, thoracic and mediastinal disorders: cough, hoarseness<BR>                        <BR>                           Skin and subcutaneous tissue disorders: exanthem, skin hyperpigmentation<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.2 	Clinical Trials Experience in Myelodysplastic Syndromes<BR>                     <BR>                        A total of 148 patients received at least 1 dose of 10 mg REVLIMID in the del 5q MDS clinical study. At least one adverse event was reported in all of the 148 patients who were treated with the 10 mg starting dose of REVLIMID. The most frequently reported adverse events were related to blood and lymphatic system disorders, skin and subcutaneous tissue disorders, gastrointestinal disorders, and general disorders and administrative site conditions.<BR>                        Thrombocytopenia (61.5%; 91/148) and neutropenia (58.8%; 87/148) were the most frequently reported adverse events. The next most common adverse events observed were diarrhea (48.6%; 72/148), pruritus (41.9%; 62/148), rash (35.8%; 53/148) and fatigue (31.1%; 46/148). Table 6 summarizes the adverse events that were reported in â‰¥ 5% of the REVLIMID treated patients in the del 5q MDS clinical study. Table 7 summarizes the most frequently observed Grade 3 and Grade 4 adverse reactions regardless of relationship to treatment with REVLIMID. In the single-arm studies conducted, it is often not possible to distinguish adverse events that are drug-related and those that reflect the patientâ€™s underlying disease.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="850" ID="table6"><BR>                           <caption>Table 6: Summary of Adverse Events Reported in &#8805;5% of the<BR>                                		REVLIMID Treated Patients in del 5q MDS Clinical Study<BR>                                		<BR>                                    </caption><BR>                           <tfoot><BR>                              <tr><BR>                                 <td colspan="3"><BR>                                    <sup>[a]</sup> System organ classes and preferred terms are coded using the MedDRA dictionary. System organ classes and preferred terms are listed in descending order of frequency for the Overall column. A patient with multiple occurrences of an AE is counted only once in the AE category.</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr styleCode="Botrule"><BR>                                 <td align="left" valign="bottom" styleCode="Lrule"><BR>                                    <content styleCode="bold">System organ class/Preferred term <sup>[a]</sup><BR>                                    </content><BR>                                 </td><BR>                                 <td align="center" colspan="2" styleCode="Rrule"><BR>                                    <content styleCode="bold">10 mg Overall<br/>(N=148)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule"> Patients with at least one adverse event        	</td><BR>                                 <td align="right">148 </td><BR>                                 <td align="right" styleCode="Rrule">(100.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Blood and Lymphatic System Disorders </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Thrombocytopenia</td><BR>                                 <td align="right"> 91 </td><BR>                                 <td align="right" styleCode="Rrule">  (61.5)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Neutropenia</td><BR>                                 <td align="right"> 87 </td><BR>                                 <td align="right" styleCode="Rrule">  (58.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Anemia</td><BR>                                 <td align="right"> 17 </td><BR>                                 <td align="right" styleCode="Rrule">  (11.5)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Leukopenia</td><BR>                                 <td align="right"> 12 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Febrile Neutropenia</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Skin and Subcutaneous Tissue Disorders </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Pruritus</td><BR>                                 <td align="right"> 62 </td><BR>                                 <td align="right" styleCode="Rrule">  (41.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Rash</td><BR>                                 <td align="right"> 53 </td><BR>                                 <td align="right" styleCode="Rrule">  (35.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Dry Skin</td><BR>                                 <td align="right"> 21 </td><BR>                                 <td align="right" styleCode="Rrule">  (14.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Contusion</td><BR>                                 <td align="right"> 12 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Night Sweats</td><BR>                                 <td align="right"> 12 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Sweating Increased</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Ecchymosis</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Erythema</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Gastrointestinal Disorders </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Diarrhea</td><BR>                                 <td align="right"> 72</td><BR>                                 <td align="right" styleCode="Rrule">  (48.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Constipation</td><BR>                                 <td align="right"> 35 </td><BR>                                 <td align="right" styleCode="Rrule">  (23.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Nausea</td><BR>                                 <td align="right"> 35 </td><BR>                                 <td align="right" styleCode="Rrule">  (23.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Abdominal Pain</td><BR>                                 <td align="right"> 18 </td><BR>                                 <td align="right" styleCode="Rrule">  (12.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Vomiting</td><BR>                                 <td align="right"> 15 </td><BR>                                 <td align="right" styleCode="Rrule">  (10.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Abdominal Pain Upper</td><BR>                                 <td align="right"> 12 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Dry Mouth</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.8)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Loose Stools</td><BR>                                 <td align="right">   9 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Rrule Lrule"><BR>                                    <content styleCode="bold"> Respiratory, Thoracic and Mediastinal Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Nasopharyngitis</td><BR>                                 <td align="right"> 34 </td><BR>                                 <td align="right" styleCode="Rrule">  (23.0)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Cough</td><BR>                                 <td align="right"> 29 </td><BR>                                 <td align="right" styleCode="Rrule">  (19.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Dyspnea</td><BR>                                 <td align="right"> 25 </td><BR>                                 <td align="right" styleCode="Rrule">  (16.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Pharyngitis</td><BR>                                 <td align="right"> 23 </td><BR>                                 <td align="right" styleCode="Rrule">  (15.5)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Epistaxis</td><BR>                                 <td align="right"> 22 </td><BR>                                 <td align="right" styleCode="Rrule">  (14.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Dyspnea Exertional</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Rhinitis</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.8)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Bronchitis</td><BR>                                 <td align="right">   9 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> General Disorders and Administration Site Conditions</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Fatigue</td><BR>                                 <td align="right"> 46 </td><BR>                                 <td align="right" styleCode="Rrule">  (31.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Pyrexia</td><BR>                                 <td align="right"> 31 </td><BR>                                 <td align="right" styleCode="Rrule">  (20.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Edema Peripheral</td><BR>                                 <td align="right"> 30 </td><BR>                                 <td align="right" styleCode="Rrule">  (20.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Asthenia</td><BR>                                 <td align="right"> 22 </td><BR>                                 <td align="right" styleCode="Rrule">  (14.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Edema</td><BR>                                 <td align="right"> 15 </td><BR>                                 <td align="right" styleCode="Rrule">  (10.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Pain</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Rigors</td><BR>                                 <td align="right">   9 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Chest Pain</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Musculoskeletal and Connective Tissue Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Arthralgia</td><BR>                                 <td align="right"> 32 </td><BR>                                 <td align="right" styleCode="Rrule">  (21.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Back Pain</td><BR>                                 <td align="right"> 31 </td><BR>                                 <td align="right" styleCode="Rrule">  (20.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Muscle Cramp</td><BR>                                 <td align="right"> 27 </td><BR>                                 <td align="right" styleCode="Rrule">  (18.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Pain in Limb</td><BR>                                 <td align="right"> 16 </td><BR>                                 <td align="right" styleCode="Rrule">  (10.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Myalgia</td><BR>                                 <td align="right"> 13 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.8)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Peripheral Swelling</td><BR>                                 <td align="right"> 12 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Nervous System Disorders </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Dizziness</td><BR>                                 <td align="right"> 29 </td><BR>                                 <td align="right" styleCode="Rrule">  (19.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Headache</td><BR>                                 <td align="right"> 29 </td><BR>                                 <td align="right" styleCode="Rrule">  (19.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Hypoesthesia</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right">    (6.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Dysgeusia</td><BR>                                 <td align="right">   9 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Peripheral Neuropathy</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Infections and Infestations </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Upper Respiratory Tract Infection</td><BR>                                 <td align="right"> 22 </td><BR>                                 <td align="right" styleCode="Rrule">  (14.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Pneumonia</td><BR>                                 <td align="right"> 17 </td><BR>                                 <td align="right" styleCode="Rrule">  (11.5)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Urinary Tract Infection</td><BR>                                 <td align="right"> 16 </td><BR>                                 <td align="right" styleCode="Rrule">  (10.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Sinusitis</td><BR>                                 <td align="right"> 12 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Cellulitis</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Metabolism and Nutrition Disorders </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Hypokalemia</td><BR>                                 <td align="right"> 16 </td><BR>                                 <td align="right" styleCode="Rrule">  (10.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Anorexia</td><BR>                                 <td align="right"> 15 </td><BR>                                 <td align="right" styleCode="Rrule">  (10.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Hypomagnesemia</td><BR>                                 <td align="right">   9 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Investigations</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Alanine Aminotransferase Increased</td><BR>                                 <td align="right"> 12 </td><BR>                                 <td align="right" styleCode="Rrule">    (8.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Psychiatric Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Insomnia</td><BR>                                 <td align="right"> 15 </td><BR>                                 <td align="right" styleCode="Rrule">  (10.1)</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Depression</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Renal and Urinary Disorders </content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Dysuria</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">  Vascular Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Hypertension</td><BR>                                 <td align="right">   9 </td><BR>                                 <td align="right" styleCode="Rrule">    ( 6.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">  Endocrine Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">  Acquired Hypothyroidism</td><BR>                                 <td align="right"> 10 </td><BR>                                 <td align="right" styleCode="Rrule">    (6.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td colspan="3" styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold"> Cardiac Disorders</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">  Palpitations</td><BR>                                 <td align="right">   8 </td><BR>                                 <td align="right" styleCode="Rrule">    (5.4)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR><BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="800" ID="table7"><BR>                           <caption>Table 7: Most Frequently Observed Grade 3 and 4 Adverse Events [1]<BR>                                		Regardless of Relationship to Study Drug Treatment<BR>                                	</caption><BR>                           <tfoot><BR>                              <tr><BR>                                 <td colspan="3"><BR>                                    <sup>[1]</sup> Adverse events with frequency &#8805;1% in the 10 mg Overall group. Grade 3 and 4 are based on National Cancer Institute Common Toxicity Criteria version 2. <br/><BR>                                    <sup>[2]</sup> Preferred Terms are coded using the MedDRA dictionary. A patient with multiple occurrences of an AE is counted only once in the Preferred Term category.</td><BR>                              </tr><BR>                           </tfoot><BR>                           <tbody><BR>                              <tr><BR>                                 <td align="left" valign="bottom" styleCode="Lrule Botrule"><BR>                                    <content styleCode="bold">Preferred term <sup>[2]</sup><BR>                                    </content><BR>                                 </td><BR>                                 <td align="center" colspan="2" styleCode="Rrule Botrule"><BR>                                    <content styleCode="bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10 mg <br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(N=148)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule">&#160;</td><BR>                                 <td>&#160;</td><BR>                                 <td styleCode="Rrule">&#160;</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule">Patients with at least one Grade 3/4 AE</td><BR>                                 <td align="right">131 </td><BR>                                 <td align="right" styleCode="Rrule">(88.5)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Neutropenia</td><BR>                                 <td align="right">  79 </td><BR>                                 <td align="right" styleCode="Rrule">(53.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Thrombocytopenia</td><BR>                                 <td align="right">  74 </td><BR>                                 <td align="right" styleCode="Rrule">(50.0) </td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pneumonia</td><BR>                                 <td align="right">  11 </td><BR>                                 <td align="right" styleCode="Rrule">  (7.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Rash</td><BR>                                 <td align="right">  10 </td><BR>                                 <td align="right" styleCode="Rrule">  (6.8)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Anemia</td><BR>                                 <td align="right">    9 </td><BR>                                 <td align="right" styleCode="Rrule">  (6.1)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Leukopenia</td><BR>                                 <td align="right">    8 </td><BR>                                 <td align="right" styleCode="Rrule">  (5.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Fatigue</td><BR>                                 <td align="right">    7 </td><BR>                                 <td align="right" styleCode="Rrule">  (4.7)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Dyspnea</td><BR>                                 <td align="right">    7 </td><BR>                                 <td align="right" styleCode="Rrule">  (4.7)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Back Pain</td><BR>                                 <td align="right">    7 </td><BR>                                 <td align="right" styleCode="Rrule">  (4.7)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Febrile Neutropenia</td><BR>                                 <td align="right">    6 </td><BR>                                 <td align="right" styleCode="Rrule">  (4.1)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Nausea</td><BR>                                 <td align="right">    6</td><BR>                                 <td align="right" styleCode="Rrule">  (4.1)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Diarrhea</td><BR>                                 <td align="right">    5 </td><BR>                                 <td align="right" styleCode="Rrule">  (3.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pyrexia</td><BR>                                 <td align="right">    5 </td><BR>                                 <td align="right" styleCode="Rrule">  (3.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Sepsis</td><BR>                                 <td align="right">    4 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.7)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Dizziness</td><BR>                                 <td align="right">    4 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.7)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Granulocytopenia</td><BR>                                 <td align="right">    3 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.0)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Chest Pain</td><BR>                                 <td align="right">    3 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.0)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pulmonary Embolism</td><BR>                                 <td align="right">    3 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.0)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Respiratory Distress</td><BR>                                 <td align="right">    3 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.0)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pruritus</td><BR>                                 <td align="right">    3 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.0)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pancytopenia</td><BR>                                 <td align="right">    3 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.0)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Muscle Cramp</td><BR>                                 <td align="right">    3 </td><BR>                                 <td align="right" styleCode="Rrule">  (2.0)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Respiratory Tract Infection</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Upper Respiratory Tract Infection</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Asthenia</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Multi-organ Failure</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Epistaxis</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4) </td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Hypoxia</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pleural Effusion</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pneumonitis</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pulmonary Hypertension</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Vomiting</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Sweating Increased</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Arthralgia</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Pain in Limb</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Headache</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                              <tr styleCode=" Botrule"><BR>                                 <td styleCode="Lrule"> &#160;&#160;&#160;&#160;&#160;Syncope</td><BR>                                 <td align="right">    2 </td><BR>                                 <td align="right" styleCode="Rrule">  (1.4)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>In other clinical studies of REVLIMID in MDS patients, the following serious adverse events (regardless of relationship to study drug treatment) not described in Table 6 or 7 were reported:<BR>                        <BR>                           Blood and lymphatic system disorders: warm type hemolytic anemia, splenic infarction, bone marrow depression, coagulopathy, hemolysis, hemolytic anemia refractory anemia<BR>                        <BR>                           Cardiac disorders: cardiac failure congestive, atrial fibrillation, angina pectoris, cardiac arrest, cardiac failure, cardio-respiratory arrest, cardiomyopathy, myocardial infarction, myocardial ischemia, atrial fibrillation aggravated, bradycardia, cardiogenic shock, pulmonary edema supraventricular arrhythmia, tachyarrhythmia, ventricular dysfunction<BR>                        <BR>                           Ear and labyrinth disorders: vertigo<BR>                        <BR>                           Endocrine disorders: Basedow's disease<BR>                        <BR>                           Gastrointestinal disorders: gastrointestinal hemorrhage, colitis ischemic, intestinal perforation, rectal hemorrhage, colonic polyp, diverticulitis, dysphagia, gastritis, gastroenteritis, gastroesophageal reflux disease, obstructive inguinal hernia, irritable bowel syndrome, melena, pancreatitis due to biliary obstruction, pancreatitis, perirectal abscess, small intestinal obstruction, upper gastrointestinal hemorrhage<BR>                        <BR>                           General disorders and administration site conditions: disease progression, fall, gait abnormal, intermittent pyrexia, nodule, rigors, sudden death<BR>                        <BR>                           Hepatobiliary disorders: hyperbilirubinemia, cholecystitis, acute cholecystitis, hepatic failure<BR>                        <BR>                           Immune system disorders: hypersensitivity <BR>                        <BR>                           Infections and infestations infection bacteremia, central line infection, clostridial infection, ear infection Enterobacter sepsis, fungal infection herpes viral infection NOS, influenza, kidney infection Klebsiella sepsis, lobar pneumonia, localized infection, oral infection, Pseudomonas infection, septic shock, sinusitis acute Â sinusitis, Staphylococcal infection, urosepsis<BR>                        <BR>                           Injury, poisoning and procedural complications: femur fracture, transfusion reaction, cervical vertebral fracture, femoral neck fracture, fractured pelvis, hip fracture, overdose, post procedural hemorrhage, rib fracture, road traffic accident, spinal compression fracture<BR>                        <BR>                           Investigations: blood creatinine increased, hemoglobin decreased, liver function tests Â abnormal, troponin I increased<BR>                        <BR>                           Metabolism and nutrition disorders: dehydration, gout, hypernatremia, hypoglycemia <BR>                        <BR>                           Musculoskeletal and connective tissue disorders: arthritis, arthritis aggravated, gouty arthritis, neck pain, chondrocalcinosis pyrophosphate<BR>                        <BR>                           Neoplasms benign, malignant and unspecified: acute leukemia, acute myeloid leukemia, bronchoalveolar carcinoma, lung cancer metastatic, lymphoma, prostate cancer metastatic<BR>                        <BR>                           Nervous system disorders: cerebrovascular accident, aphasia, cerebellar infarction, cerebral infarction, depressed level of consciousness, dysarthria, migraine, spinal cord compression, subarachnoid hemorrhage, transient ischemic attack<BR>                        <BR>                           Psychiatric disorders: confusional state<BR>                        <BR>                           Renal and urinary disorders: renal failure, hematuria, renal failure acute, azotemia, calculus ureteric, renal mass <BR>                        <BR>                           Reproductive system and breast disorders: pelvic pain <BR>                        <BR>                           Respiratory, thoracic and mediastinal disorders: bronchitis, chronic obstructive airways disease exacerbated, respiratory failure, dyspnea exacerbated, interstitial lung disease, lung infiltration, wheezing<BR>                        <BR>                           Skin and subcutaneous tissue disorders: acute febrile neutrophilic dermatosis<BR>                        <BR>                           Vascular system disorders: deep vein thrombosis, hypotension, aortic disorder, ischemia, thrombophlebitis superficial, thrombosis<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.3	Postmarketing Experience<BR>                     <BR>                        The following adverse drug reactions have been identified from the worldwide post-marketing experience with REVLIMID. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure:  Allergic conditions (angioedema, SJS, TEN), tumor lysis syndrome (TLS) and tumor flare reaction (TFR), pneumonitis, and transient abnormal liver laboratory tests. [see Warnings and Precautions Section (5.5 to 5.8)].<BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>